Related Experiment Video
Updated: Jun 7, 2025
12:18
LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
5.7K
Classification of pediatric soft and bone sarcomas using DNA methylation-based profiling.
Felipe Luz Torres Silva1,2, Mayara Ferreira Euzébio1,2, Juliana Silveira Ruas1
1Research Center, Boldrini Children's Hospital, Rua Marcia Mendes, 619, Cidade Universitaria, CEP 13083-884, Campinas, São Paulo, Brazil.
BMC Cancer
|November 20, 2024
Summary
DNA methylation profiling accurately classified pediatric sarcomas, confirming diagnoses and reclassifying Ewing-like tumors. This molecular approach aids in diagnosing challenging pediatric sarcoma cases.
Area of Science:
- Oncology
- Epigenetics
- Genomics
Background:
- Pediatric sarcomas exhibit diverse characteristics, complicating accurate diagnosis.
- DNA methylation is a crucial epigenetic regulator of gene expression and cell identity.
Purpose of the Study:
- To evaluate the utility of a DNA methylation-based sarcoma classifier in pediatric sarcoma diagnosis.
- To compare molecular classification with traditional histopathology and clinical assessment.
Main Methods:
- Applied a DNA methylation profiling classifier to 122 pediatric sarcomas.
- Utilized orthogonal diagnostic techniques for confirmation.
- Analyzed copy number alterations (CNAs) profiles.
Main Results:
- Achieved 88.5% agreement between molecular and histopathological classifications.
- Confirmed diagnoses for osteosarcomas and Ewing sarcomas.
- Reclassified Ewing-like sarcomas based on BCOR or CIC alterations.
- Identified distinct CNA profiles for osteosarcomas and Ewing sarcomas.
Conclusions:
- DNA methylation profiling enhances pediatric sarcoma diagnosis, especially for challenging cases.
- Molecular classification, combined with clinical and histopathological data, improves diagnostic accuracy.
- Further research is needed for rare pediatric sarcoma subtypes.
